Vyant Bio (VYNT) Reports Q1 Loss from Cont. Operations of $0.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results
May 16, 2022 4:15 PM EDT Q1 Revenue of $10.4 million up 6% versus Prior Year Q1 Net Loss improved $2 million versus Prior... More



